TD Asset Management »

Neurogene shares owned by TD Asset Management

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by TD Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $361k 16k 22.86

More positions owned by TD Asset Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Rbc Cad (RY)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Meta Platforms Cl A (META)
Bank Of Montreal Cadcom (BMO)
Broadcom (AVGO)
Enbridge (ENB)
Cibc Cad (CM)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Brookfield Corp Cl A Ltd Vt Sh (BN)
JPMorgan Chase & Co. (JPM)
Agnico (AEM)

View all positions for TD Asset Management

Top funds holding Neurogene

Samsara BioCapital
Rtw Investments
Redmile Group
Casdin Capital
EcoR1 Capital
Baker Bros. Advisors
BlackRock
Balyasny Asset Management
Toronto-Dominion Bank
Vanguard Group
Arrowpoint Asset Management
Morgan Stanley
Dr. Jeffrey R. Jay, M.D.
Jennison Associates
Octagon Capital Advisors

View all funds holding Neurogene